title: Qaly Weightings Based on the Burden of Illness Applied to a Uk Cost-Effectiveness Analysis of Nab-Paclitaxel + Gemcitabine Versus Gemcitabine Alone for the Treatment of Metastatic Pancreatic Cancer.
authors.affiliation: Celgene UK, Uxbridge, UK.
authors.forename: W
authors.initials: W
authors.lastname: Cowell
authors.affiliation: BresMed Health Solutions LTD, Sheffield, UK.
authors.forename: D
authors.initials: D
authors.lastname: Gladwell
authors.affiliation: Celgene International Sarl, Boudry, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Parnaby